Meeting of the Presidential Advisory Council on HIV/AIDS, 11047 [2017-03245]

Download as PDF Federal Register / Vol. 82, No. 32 / Friday, February 17, 2017 / Notices who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person at least fourteen (14) business days prior to the meeting. Members of the public will have an opportunity to provide comments at the meeting. Public comments will be limited to three minutes per speaker. Individuals who would like to submit written statements should mail or fax their comments to the Office of Minority Health at least seven (7) business days prior to the meeting. Any members of the public who wish to have printed material distributed to ACMH committee members should submit their materials to the Designated Federal Officer, ACMH, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852, prior to close of business on Thursday, March 16, 2017. Dated: February 14, 2017. Minh Wendt, Designated Federal Officer, ACMH, Office of Minority Health, U.S. Department of Health and Human Services. [FR Doc. 2017–03247 Filed 2–16–17; 8:45 am] BILLING CODE 4150–29–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Presidential Advisory Council on HIV/AIDS Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the Presidential Advisory Council on HIV/ AIDS (PACHA or the Council) will be holding a meeting to continue discussions and possibly develop recommendations regarding People Living with HIV/AIDS. The meeting will be open to the public. DATES: The Council meeting is scheduled to be held on March 13, 2017, from 9:00 a.m. to approximately 5:00 p.m. (ET) and March 14, 2017, from 9:00 a.m. to approximately 12:00 p.m. (ET). The meeting will be open to the public. ADDRESSES: 330 Independence Avenue SW., Washington, DC 20201 in the Snow Room (Conference Room 5051). FOR FURTHER INFORMATION CONTACT: Ms. Caroline Talev, Public Health Analyst, Presidential Advisory Council on HIV/ mstockstill on DSK3G9T082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:38 Feb 16, 2017 Jkt 241001 AIDS, 330 C Street SW., Room L106B, Washington, DC 20024; (202) 795–7622 or Caroline.Talev@hhs.gov. More detailed information about PACHA can be obtained by accessing the Council’s page on the AIDS.gov Web site at www.aids.gov/pacha. SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order 12963, dated June 14, 1995, as amended by Executive Order 13009, dated June 14, 1996. In a memorandum, dated July 13, 2010, and under Executive Order 13703, dated July 30, 2015, the President gave certain authorities to the PACHA for implementation of the National HIV/AIDS Strategy for the United States (Strategy). PACHA is currently operating under the authority given in Executive Order 13708, dated September 30, 2015. PACHA provides advice, information, and recommendations to the Secretary regarding programs, policies, and research to promote effective treatment, prevention, and cure of HIV disease and AIDS, including considering common co-morbidities of those infected with HIV as needed, to promote effective HIV prevention and treatment and quality services to persons living with HIV disease and AIDS. Substantial progress has been made in addressing the domestic HIV epidemic since the Strategy was released in July 2010. Under Executive Order 13703, the National HIV/AIDS Strategy for the United States: Updated to 2020 (Updated Strategy) was released. PACHA shall contribute to the federal effort to improve HIV prevention and care. The functions of the Council are solely advisory in nature. The Council consists of not more than 25 members. Council members are selected from prominent community leaders with particular expertise in, or knowledge of, matters concerning HIV and AIDS, public health, global health, philanthropy, marketing or business, as well as other national leaders held in high esteem from other sectors of society. Council members are appointed by the Secretary or designee, in consultation with the White House Office on National AIDS Policy. The agenda for the upcoming meeting will be posted on the AIDS.gov Web site at www.aids.gov/pacha. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Caroline Talev at Caroline.Talev@hhs.gov. Due to space constraints, pre-registration for PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 11047 public attendance is advisable and can be accomplished by contacting Caroline Talev at Caroline.Talev@hhs.gov by close of business on Monday, March 6, 2017. Members of the public will have the opportunity to provide comments during the meeting. Comments will be limited to two minutes per speaker. Any individual who wishes to participate in the public comment session must register with Caroline Talev at Caroline.Talev@hhs.gov by close of business on Monday, March 6, 2017; registration for public comment will not be accepted by telephone. Individuals are encouraged to provide a written statement of any public comment(s) for accurate minute taking purposes. Public comment will be limited to two minutes per speaker. Any members of the public who wish to have printed material distributed to PACHA members at the meeting are asked to submit, at a minimum, 1 copy of the material(s) to Caroline Talev, no later than close of business on Monday, March 6, 2017. Dated: February 9, 2017. B. Kaye Hayes, Executive Director, Presidential Advisory Council on HIV/AIDS. [FR Doc. 2017–03245 Filed 2–16–17; 8:45 am] BILLING CODE 4150–43–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel Review of RFA–TR–16–021: Coordination Center for the CTSA Program (U24). Date: March 14, 2017. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\17FEN1.SGM 17FEN1

Agencies

[Federal Register Volume 82, Number 32 (Friday, February 17, 2017)]
[Notices]
[Page 11047]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03245]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Presidential Advisory Council on HIV/AIDS

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of the Assistant Secretary for Health.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services is hereby giving notice that 
the Presidential Advisory Council on HIV/AIDS (PACHA or the Council) 
will be holding a meeting to continue discussions and possibly develop 
recommendations regarding People Living with HIV/AIDS. The meeting will 
be open to the public.

DATES: The Council meeting is scheduled to be held on March 13, 2017, 
from 9:00 a.m. to approximately 5:00 p.m. (ET) and March 14, 2017, from 
9:00 a.m. to approximately 12:00 p.m. (ET). The meeting will be open to 
the public.

ADDRESSES: 330 Independence Avenue SW., Washington, DC 20201 in the 
Snow Room (Conference Room 5051).

FOR FURTHER INFORMATION CONTACT: Ms. Caroline Talev, Public Health 
Analyst, Presidential Advisory Council on HIV/AIDS, 330 C Street SW., 
Room L106B, Washington, DC 20024; (202) 795-7622 or 
Caroline.Talev@hhs.gov. More detailed information about PACHA can be 
obtained by accessing the Council's page on the AIDS.gov Web site at 
www.aids.gov/pacha.

SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order 
12963, dated June 14, 1995, as amended by Executive Order 13009, dated 
June 14, 1996. In a memorandum, dated July 13, 2010, and under 
Executive Order 13703, dated July 30, 2015, the President gave certain 
authorities to the PACHA for implementation of the National HIV/AIDS 
Strategy for the United States (Strategy). PACHA is currently operating 
under the authority given in Executive Order 13708, dated September 30, 
2015.
    PACHA provides advice, information, and recommendations to the 
Secretary regarding programs, policies, and research to promote 
effective treatment, prevention, and cure of HIV disease and AIDS, 
including considering common co-morbidities of those infected with HIV 
as needed, to promote effective HIV prevention and treatment and 
quality services to persons living with HIV disease and AIDS.
    Substantial progress has been made in addressing the domestic HIV 
epidemic since the Strategy was released in July 2010. Under Executive 
Order 13703, the National HIV/AIDS Strategy for the United States: 
Updated to 2020 (Updated Strategy) was released. PACHA shall contribute 
to the federal effort to improve HIV prevention and care.
    The functions of the Council are solely advisory in nature.
    The Council consists of not more than 25 members. Council members 
are selected from prominent community leaders with particular expertise 
in, or knowledge of, matters concerning HIV and AIDS, public health, 
global health, philanthropy, marketing or business, as well as other 
national leaders held in high esteem from other sectors of society. 
Council members are appointed by the Secretary or designee, in 
consultation with the White House Office on National AIDS Policy. The 
agenda for the upcoming meeting will be posted on the AIDS.gov Web site 
at www.aids.gov/pacha.
    Public attendance at the meeting is limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify Caroline Talev at Caroline.Talev@hhs.gov. Due to space 
constraints, pre-registration for public attendance is advisable and 
can be accomplished by contacting Caroline Talev at 
Caroline.Talev@hhs.gov by close of business on Monday, March 6, 2017. 
Members of the public will have the opportunity to provide comments 
during the meeting. Comments will be limited to two minutes per 
speaker. Any individual who wishes to participate in the public comment 
session must register with Caroline Talev at Caroline.Talev@hhs.gov by 
close of business on Monday, March 6, 2017; registration for public 
comment will not be accepted by telephone. Individuals are encouraged 
to provide a written statement of any public comment(s) for accurate 
minute taking purposes. Public comment will be limited to two minutes 
per speaker. Any members of the public who wish to have printed 
material distributed to PACHA members at the meeting are asked to 
submit, at a minimum, 1 copy of the material(s) to Caroline Talev, no 
later than close of business on Monday, March 6, 2017.

    Dated: February 9, 2017.
B. Kaye Hayes,
Executive Director, Presidential Advisory Council on HIV/AIDS.
[FR Doc. 2017-03245 Filed 2-16-17; 8:45 am]
 BILLING CODE 4150-43-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.